Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
95.42
+0.11 (0.12%)
At close: May 12, 2025, 4:00 PM
95.42
0.00 (0.00%)
After-hours: May 12, 2025, 4:39 PM EDT
Amedisys Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Amedisys stock have an average target of 100.8, with a low estimate of 100 and a high estimate of 101. The average target predicts an increase of 5.64% from the current stock price of 95.42.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amedisys stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 5 | 6 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 6 | 7 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | +4.80% | Apr 16, 2025 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +5.85% | Mar 4, 2025 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +5.85% | Feb 12, 2025 |
Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +5.85% | Jul 31, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +5.85% | Jul 25, 2024 |
Financial Forecast
Revenue This Year
2.50B
from 2.35B
Increased by 6.46%
Revenue Next Year
2.63B
from 2.50B
Increased by 5.00%
EPS This Year
4.79
from 1.31
Increased by 265.64%
EPS Next Year
5.25
from 4.79
Increased by 9.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.6B | 2.8B | 2.8B |
Avg | 2.5B | 2.6B | 2.8B |
Low | 2.4B | 2.4B | 2.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 11.1% | 10.6% | 8.2% |
Avg | 6.5% | 5.0% | 5.1% |
Low | 0.5% | -2.8% | 1.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 5.53 | 5.96 | 5.49 |
Avg | 4.79 | 5.25 | 5.33 |
Low | 4.30 | 4.67 | 5.13 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 322.4% | 24.5% | 4.6% |
Avg | 265.6% | 9.6% | 1.7% |
Low | 228.4% | -2.4% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.